Page 86 - วารสารปีที่17ฉบับที่1
P. 86
76 วารสารการแพทย์แผนไทยและการแพทย์ ทางเลือก ปีที่ 17 ฉบับที่ 1 มกราคม-เมษายน 2562
อนุเคราะห์อนุญาตให้เก็บข้อมูลในร้านยา ขอขอบคุณ tochemistry, Faculty of Pharmacy. Bangkok: Mahidol
University; 2004. (in Thai)
เภสัชกรประจำาร้านและเจ้าหน้าที่ทุกท่านที่ช่วยเหลือ 9. Kamalashiran C, Lekskulchai O. The comparative study
และอำานวยความสะดวกในการเก็บข้อมูล ขอบคุณ of the efficacy and side effect of Prasaplai extract versus
ผู้เข้าร่วมวิจัยทุกท่าน Mefenamic acid on relieving primary dysmenorrhea:
A clinical phase II trials. Thammasat Medical Journal.
2012;12(4):749-56. (in Thai)
10. Sasum S. The development of Prasaplai capsule extract
References and efficacy for relieving primary dysmenorrhea (dis-
1. Thongsong T, Srisombul J, Olanratanachai A. Gynecol- sertation). Mahasarakham: Mahasarakham University;
ogy. 2nd ed. Bangkok: BP Florence book center; 1996. 2010. (in Thai)
674 p. (in Thai) 11. Vannabhum M, Poopong S, Wongwananuruk T, Nim-
2. Heinemann LA, Minh TD, Heinemann K, Lindemann mannit A, Suwannatrai U, Dangrat C, Apichartvorakit
M, Filonenko A. Intercountry assessment of the im- A, Booranasubkajorn S, Laohapand T, Akaraserenont
pact of severe premenstrual disorders on work and P. The Efficacy of Thai Herbal Prasaplai Formula for
daily activities. Health Care for Women International. Treatment of Primary Dysmenorrhea: A Short-Term
2012;33(2):109-24. Randomized Controlled Trial. Evid Based Complement
3. Rowland AS, Baird DD, Long S, Wegienka G, Harlow SD, Alternat Med. 2016;2016:2096797.
Alavanja M, Sandler DP. Influence of medical conditions 12. Cohen J. A power primer. Psychological Bulletin.
and lifestyle factors on the menstrual cycle. Epidemiol- 1992;112(1):155-9.
ogy. 2002;13(6):668–74. 13. Hofmeister S, Bodden S. Premenstrual syndrome and
4. Matteson KA, Raker CA, Clark MA, Frick KD. Abnormal premenstrual dysphoric disorder. Am Fam Physician.
uterine bleeding, health status, and usual source of med- 2016;94(3):236-40.
ical care: analyses using the Medical Expenditures Panel 14. Tangchai K, Titapant V, Boriboonhirunsarn D. Dysmen-
Survey. J Womens Health (Larchmt). 2013;22(11):959-65. orrhea in Thai adolescents: prevalence, impact and
5. Bureau of drug control. Production cost and import knowledge of treatment. J Med Assoc Thai. 2004;87
medication into Thailand 1997-2008. [Internet]. 2008 Suppl3:S69-73.
[cited 2014 Jan 15]; Available from: http://wwwpp1.fda. 15. Ittharat A, et al. The report of efficacy and safety of
moph.go.th./drug/zone_search/file/sea001_001.asp. (in Prasaplai for using in obstetrics and gynecology. Bang-
Thai) kok: Thammasat University; 2009. (in Thai)
6. National List of Essential Medicines B.E. 2558 (2015). 16. Nualkaew S, Tiangda C, Gritsanapan W. Inhibitory
Thailand B.E. 2558 (2015), Government Gazette, Vol. action on rat uterine muscle contraction in vitro and
132, Part 184 ngor. (10 Aug 2015). (in Thai) acute toxicity in rats of the Thai traditional preparation
7. Boongen M. Study on Formulation and Stability Test Prasaplai. Nat Prod Res. 2013;27(4-5):491-5.
of Prasaplai Extract Tablets and Capsules for dysmen- 17. Waltenberger B, Schuster D, Paramapojn S, Gritsanapan
norhea (thesis). Medical Sciences, Faculty of Medicine. W, Wolber G, Rollinger JM, Stuppner H. Predicting
Bangkok: Thammasat University; 2011. (116 p.). (in Thai) cyclooxygenase inhibition by three-dimensional phar-
8. Nualkaew S. Phytochemical and pharmacological stud- macophoric profiling. Part II: Identification of enzyme
ies of a Thai traditional preparation: Prasaplai (thesis). inhibitors from Prasaplai, a Thai traditional medicine.
Pharmaceutical Chemistry and Pharmaceutical Phy- Phytomedicine. 2011;18(2-3):119-33.
